5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Sai Life Sciences Ltd.

•
sailife.comBSE: 544306NSE: SAILIFE
Market Cap₹ 35,579 Cr.
Current Price
High / Low₹ 1,697 / 784
Stock P/E100.4
Book Value₹ 121
Price to Book8.21
Dividend Yield0.00 %
ROCE20.0 %
ROE14.6 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 39.2% CAGR over last 5 years
  • Company is almost debt free
  • Company has delivered good sales growth of 23.4% CAGR over last 5 years
  • Operating margins have improved to 26.7% from 16.8%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.76x)

CONS

  • Promoter holding has decreased over last 2 years: -3.4pp
  • Equity base is being diluted - shares outstanding up 20.2%
  • Stock is trading at 8.2x its book value
  • Though reporting repeated profits, the company pays out little dividend (0.0%)
  • Rich enterprise valuation - EV/EBITDA of 31.6x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY PHARMANIFTY500MOMENTM50NIFTY SMLCAP 250NIFTY SMLCAP 50NIFTY 500
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.SAILIFE1675.1598.3635579.220.0073.2821.22554.2911.6620.9726.70
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
373428264382429567483527549594547
279301240281317413370387370426455
Operating Profit941272510111115411314017916892
OPM %25.10%29.60%9.30%26.38%25.94%27.14%23.39%26.55%32.59%28.29%16.79%
11481091010150164
Interest22192019229118866
Depreciation2828283331343436414142
Profit before Tax5483-1558681207811113013795
Tax %25.78%26.18%24.93%25.05%24.83%25.34%25.15%25.18%25.17%25.08%25.17%
Net Profit4062-1144519058839810371
2.223.39-0.632.352.744.322.803.974.644.853.36

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
4455266957257518411,1571,4191,6422,1532,217
3684265205555877169911,1311,2501,5771,638
Operating Profit77100175170164125167288392576579
OPM %17.26%19.00%25.13%23.42%21.85%14.85%14.42%20.30%23.89%26.76%26.11%
19761827282829376635
Interest1217242132517481723428
Depreciation21274452728088107126152160
Profit before Tax6362112114882233129232456474
Tax %25.35%32.98%35.06%29.75%25.44%29.84%25.85%26.18%25.14%25.14%25.15%
Net Profit4742738065162495173341354
EPS32.7229.3751.5448.9537.888.8213.2953.928.3216.12—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
18%
5 Years:
23%
3 Years:
23%

COMPOUNDED PROFIT GROWTH

10 Years:
26%
5 Years:
39%
3 Years:
142%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
85%

RETURN ON EQUITY

10 Years:
10%
5 Years:
8%
3 Years:
12%
Last Year:
15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

No bonus data found

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital14141616171818182121
3023466977728438648859832,1422,482
198229288327658880840774236162
Trade Payables4897108137144193197136333307
8882103137154151202376466728
Total Liabilities6517681,2121,3891,8162,1062,1412,2873,1973,700
2723073736177028589231,0741,3781,705
Capital Work in Progress91411679192189151107124270
0002263648080114163
447344437312613886118150
0000000259353370
Cash & Bank1315247937012480152458108
312359431535715747769529652935
Total Assets6517681,2121,3891,8162,1062,1412,2873,1973,700

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
3859155128-996226251330495
Cash from Investing-69-62-158-259-279-95-111-190-565-393
Cash from Financing4512268-130481-190-85314-109
-6-1237-152-275-80-2480-7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2023Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
37.9135.2435.2435.1735.1534.9434.7034.6134.53
0.007.6311.7212.3614.5722.5021.4121.1719.65
0.005.6111.9513.2621.6429.9231.4131.5432.71
Government0.000.000.000.000.000.000.000.000.00
56.1051.5241.0939.2128.6412.6512.4912.6813.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Sai Life Sciences Limited has informed the Exchange about Schedule of meet

2026-09-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Sai Life Sciences Limited has informed the Exchange about Schedule of meet

2026-09-01
ESOP/ESOS/ESPS

2026-09-01 - Sai Life Sciences Limited has informed the Exchange regarding Allotment of 80600 Shares.

2026-08-26
Copy of Newspaper Publication

2026-08-26 - Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-25
Updates

2026-08-25 - Sai Life Sciences Limited has informed the Exchange regarding 'Web Link Letters to Shareholders'.

2026-08-25
Shareholders meeting

2026-08-25 - Sai Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 17, 2026

2026-08-24
Copy of Newspaper Publication

2026-08-24 - Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-24
Updates

2026-08-24 - Sai Life Sciences Limited has informed the Exchange regarding 'Information relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.'.

2026-08-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-12 - Sai Life Sciences Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for SAILIFE

Loading news…

🤖

AI Stock Analyst

Sai Life Sciences Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login